The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its ...
Why Black participation in heart health clinical trials is crucial and how it can lead to better healthcare outcomes for the community.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...
Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal ...
Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing ...
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Ledger-Enquirer on MSN5d
Health Care News: Centricity Research expands footprint in Columbus, GACentricity Research celebrated the opening of its new clinical research facility at 910 Talbotton Rd. in Columbus, Georgia on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback